Intelligence

Analysis

When a doublet is the signal: interpreting T:B conjugates with flow and imaging

Blinatumomab can create the very cell complexes a routine singlet gate excludes. A 2026 experimental study reveals why their fluorescence can mislead T-cell memory phenotyping.

The first thing a cytometrist learns is to exclude doublets. But that instinct creates a paradox in functional immunology: a T cell physically bound to its malignant target is exactly the event that a routine singlet gate would discard. In assays designed to follow bispecific antibody engagement, the analytical object is no longer an isolated cell. It is the interaction.

Davis and colleagues examined this distinction in a 2026 Cytometry Part A study of blinatumomab-mediated T-cell and B-cell line conjugates. Their approach paired conventional flow cytometry with imaging cytometry and asked two questions: can both platforms find target–effector multimers, and can conventional fluorescence correctly describe the memory phenotype of T cells within those complexes?

Original CFCM conceptual figure contrasting routine singlet-based immunophenotyping, deliberately retained T-to-B cell conjugates, imaging validation of multicellular synapses, and interpretation limits.
Original CFCM conceptual diagram. Educational synthesis; not clinical validation.

When a doublet is the measurement

The researchers purified T cells from healthy donors, labelled CD19-positive target lines using CellTrace Violet and incubated cells with or without blinatumomab for one hour. Their conventional acquisition used a BD LSR Fortessa, with CD4 and CD8 defining the bound T-cell combinations. Unlike a routine single-cell diagnostic analysis, they enlarged the FSC/SSC acquisition and analysis regions and omitted the SSC-area/height singlet-exclusion step. A gate restricted to small, apparently individual cells would have systematically depleted the largest complexes of interest.

They observed a roughly five- to fifteenfold increase in detected target–T-cell conjugate formation in the three cell lines studied compared with no-drug controls. The comparison involved four independent experiments with different healthy donors. This fold-change is an assay observation, not a patient-response estimate. Imaging cytometry confirmed multicellular conjugates; phalloidin localized F-actin at contact regions consistent with immune synapse formation.

Why the memory phenotype looked younger than the cells

The result that deserves special attention is a misleading co-expression pattern. When several T cells were bound to the same target, the resulting event showed increased CCR7 and CD45RA fluorescence. Read as though the event represented one T cell, that signal could create an apparent expansion of naïve-like or TEMRA-like populations. Imaging made the explanation visible: a single cytometer event could include multiple effector cells. Combining their fluorescence is not equivalent to assigning one lineage or differentiation state.

The study also considered target-cell autofluorescence and additional memory markers. Its conclusion was not that blinatumomab specifically preferred naïve T cells, but that multicellular measurements confound the interpretation of conventional single-cell markers. This is a warning against inferring differentiation states from aggregate events without validating what each event represents.

What conventional and imaging flow each contributes

Conventional flow can efficiently acquire large numbers of events and support broader phenotypic panels. Imaging flow adds morphology and spatial evidence: whether the CD4 and CD8 signals are present on distinct cells, whether several cells are contacting the target, and whether synapse-associated F-actin is positioned at an interface. The authors compared the methods directly in two independent donor experiments, a modest cross-platform sample. In their setup, imaging data files constrained the event count to fewer than 5,000 per sample. Neither approach alone established clinical prognostic utility.

Two gating contracts that must not be confused

Routine immunophenotyping and MRD: the purpose of singlet exclusion is to avoid false co-expression, corrupted counts and compound events. Aggregates remain an analytical concern. Cell-interaction functional assay: retaining conjugates may be essential, but the laboratory must validate target identification, controls without engagement, acquisition geometry, imaging confirmation, repeatability and a defensible denominator. Adapting the latter gate to routine MRD by default would invert the assay's analytical objective.

The mechanistic relevance to bispecific antibodies and CAR T-cell research is promising, but these experiments used healthy-donor T cells and model cell lines rather than a prospectively validated patient outcome cohort. The frequency of captured synapses is not a validated marker of clinical treatment response.

Daily Learning Pill: Before excluding—or deliberately retaining—cell aggregates, define what one recorded event is meant to represent. A cytometry gate is valid only relative to the biological quantity the assay intends to measure.

Evidence: Davis JE et al. Cytometry Part A, published 28 May 2026, DOI 10.1002/cyto.a.70039. This is an original CFCM technical interpretation of a peer-reviewed in-vitro methods study, not an independent clinical validation. The proposed figure is original conceptual artwork; no publisher figure is reproduced.